After spending over $100 million last year alone, with projections rising sharply for both Medicaid and employee health plans, state leaders are trialing innovative solutions that could transform drug affordability nationwide. Connecticut has now taken a historic step in this fight against rising costs, by pursuing federal approval to develop a generic alternative, a move that could reshape access and affordability for millions. In this closing keynote, learn into the state’s vision, the policy roadmap ahead, and what it could mean for patients, payers, and innovation in healthcare. Join us for this essential conversation on the future of accessible healthcare.
